Clinical Trials Browser

Interventional × Burkitt Lymphoma × CPX-351 × Clear all

Burkitt Lymphoma, Leukemia, Lymphoid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05320380 2023-09-01

A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01943682 2020-11-09

Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma

Phase 1 Completed

27 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia

A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma